View in EDS

Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer.

Saved in:
Bibliographic Details
Title: Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer.
Authors: McCrudden CM; 1School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL Northern Ireland, UK., McBride JW; 1School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL Northern Ireland, UK., McCaffrey J; 1School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL Northern Ireland, UK., McErlean EM; 1School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL Northern Ireland, UK., Dunne NJ; 2School of Mechanical and Manufacturing Engineering, Dublin City University, Dublin, Ireland., Kett VL; 1School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL Northern Ireland, UK., Coulter JA; 1School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL Northern Ireland, UK., Robson T; 3Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin 2, Ireland., McCarthy HO; 1School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL Northern Ireland, UK.
Source: Cancer nanotechnology [Cancer Nanotechnol] 2018; Vol. 9 (1), pp. 5. Date of Electronic Publication: 2018 Jun 01.
Publication Type: Journal Article
Journal Info: Publisher: Springer Wien Country of Publication: Austria NLM ID: 101516978 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1868-6958 (Print) Linking ISSN: 18686958 NLM ISO Abbreviation: Cancer Nanotechnol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1868-6958
DOI:10.1186/s12645-018-0040-x